Carboxypeptidase class drugs

1 result
BTG International Inc.
Usage: VORAXAZE is indicated for reducing toxic plasma methotrexate concentrations in adults and pediatric patients with delayed clearance due to impaired renal function. It is not recommended for patients with expected methotrexate clearance, as this may lead to inadequate therapeutic exposure.